A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound

• Main Authors: Iris C. Salaroglio (Author), Denitsa Stefanova (Author), Ricardo G. Teixeira (Author), Nuno F.B. Oliveira (Author), Amer Ahmed (Author), Fabio Fusi (Author), Virginia Tzankova (Author), Yordan Yordanov (Author), Miguel Machuqueiro (Author), Simona Saponara (Author), Andreia Valente (Author), Chiara Riganti (Author)
• Format: Book
• Published: Elsevier, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The therapeutic approach to many solid tumors, including non-small cell lung cancer (NSCLC), is mainly based on the use of platinum-containing anticancer agents and is often characterized by acquired or intrinsic resistance to the drug. Therefore, the search for safer and more effective drugs is sti...